Colorectal cancer: proportion of patients with colorectal cancer who die within 30 or 90 days of chemotherapy or radiotherapy treatment with curative intent.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory/Office-based Care, Ambulatory Procedure/Imaging Center, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Colorectal cancer: proportion of patients between 50 and 74 years of age at diagnosis with Dukes C, or high risk Dukes B, colorectal cancer who undergo surgical resection who receive adjuvant chemotherapy.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory/Office-based Care, Ambulatory Procedure/Imaging Center, Hospital Inpatient, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Colorectal cancer: proportion of patients with colorectal cancer who die within 30 or 90 days of emergency or elective surgical resection.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Hospital Inpatient
- Professionals Involved In the Delivery of Service
Colorectal cancer: proportion of patients with rectal cancer who undergo a surgical procedure involving anastomosis of the rectum (including anterior resection with total mesorectal excision ) having anastomotic leak requiring intervention (radiological or surgical).
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Hospital Inpatient
- Professionals Involved In the Delivery of Service
Colorectal cancer: proportion of patients with colorectal cancer who undergo a surgical procedure involving anastomosis of the colon having anastomotic leak requiring intervention (radiological or surgical).
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Hospital Inpatient
- Professionals Involved In the Delivery of Service
Colorectal cancer: proportion of patients who undergo surgical resection for colorectal cancer who return to theatre to deal with complications related to the index procedure (within 30 days of surgery).
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Hospital Inpatient
- Professionals Involved In the Delivery of Service
Colorectal cancer: proportion of patients with rectal cancer who undergo elective surgical resection following neo-adjuvant long course radiotherapy or chemoradiotherapy in which the circumferential margin is clear of tumour.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Hospital Inpatient
- Professionals Involved In the Delivery of Service
Colorectal cancer: proportion of patients with rectal cancer who undergo elective primary surgical resection or surgical resection following short course neo-adjuvant radiotherapy in which the circumferential margin is clear of tumour.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Hospital Inpatient
- Professionals Involved In the Delivery of Service
Colorectal cancer: proportion of patients with rectal cancer with threatened or involved circumferential resection margin (CRM) on pre-operative MRI who receive long course neo-adjuvant chemoradiotherapy.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory/Office-based Care, Ambulatory Procedure/Imaging Center, Hospital Inpatient, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Colorectal cancer: proportion of patients with colorectal cancer who undergo curative surgical resection where greater than or equal to 12 lymph nodes are pathologically examined.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Hospital Inpatient
- Professionals Involved In the Delivery of Service
Colorectal cancer: proportion of patients with colorectal cancer who undergo elective surgical resection which involves stoma creation who are seen and have their stoma site marked pre-operatively by a nurse with expertise in stoma care.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Hospital Inpatient
- Professionals Involved In the Delivery of Service
Colorectal cancer: proportion of patients with colorectal cancer who are discussed at a multidisciplinary team (MDT) meeting before definitive treatment.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory/Office-based Care, Ambulatory Procedure/Imaging Center, Hospital Inpatient, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Colorectal cancer: proportion of patients with colorectal cancer who undergo elective surgical resection who have the whole colon visualised by colonoscopy or CT colonography before surgery, unless the non-visualised segment of colon is to be removed.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory/Office-based Care, Ambulatory Procedure/Imaging Center, Hospital Inpatient, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Colorectal cancer: proportion of patients with rectal cancer undergoing definitive treatment (chemoradiotherapy or surgical resection) who undergo CT chest, abdomen and pelvis and MRI pelvis before definitive treatment.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory/Office-based Care, Ambulatory Procedure/Imaging Center, Hospital Inpatient, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Colorectal cancer: proportion of patients with colon cancer who undergo CT chest, abdomen and pelvis before definitive treatment.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory/Office-based Care, Ambulatory Procedure/Imaging Center, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Cutaneous melanoma: proportion of patients with cutaneous melanoma undergoing groin block dissection who have been referred to a lymphoedema service.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Hospital Inpatient, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Cutaneous melanoma: proportion of patients with unresectable stage III and IV cutaneous melanoma who undergo systemic anti-cancer therapy (SACT).
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory/Office-based Care, Ambulatory Procedure/Imaging Center, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Cutaneous melanoma: proportion of patients with stage III and IV cutaneous melanoma who undergo CT or positron emission tomography (PET) CT prior to completion lymphadenectomy.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory Procedure/Imaging Center, Hospital Inpatient, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Cutaneous melanoma: proportion of patients with unresectable stage III or IV cutaneous melanoma who have their BRAF status checked.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory/Office-based Care, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Cutaneous melanoma: proportion of patients with cutaneous melanoma undergoing wide local excision within 84 days of their partial biopsy.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory Procedure/Imaging Center, Hospital Inpatient, Hospital Outpatient
- Professionals Involved In the Delivery of Service